Clinical Trials Browser

Recurrence × Sorafenib × Plasma cell × Clear all

NCT00536575 2013-02-27

Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients

Phase 1/2 Completed

13 enrolled 5 charts

Multiple Myeloma, Recurrence